Protection from pulmonary fibrosis in leukotriene-deficient mice (Q43854271)

27 November 2017

Protection from pulmonary fibrosis in leukotriene-deficient mice (English)

1 reference

27 November 2017

1 reference

7

1 reference

27 November 2017

1

Marc Peters-Golden

1 reference

27 November 2017

Marc Bailie

2

1 reference

27 November 2017

Teresa Marshall

3

1 reference

27 November 2017

Carol Wilke

4

1 reference

27 November 2017

Sem H Phan

5

1 reference

27 November 2017

Galen B Toews

6

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

American Journal of Respiratory and Critical Care Medicine

27 November 2017

1 reference

27 November 2017

165

1 reference

27 November 2017

2

1 reference

27 November 2017

229-235

1 reference

NHLBI Workshop Summary. Pharmacological therapy for idiopathic pulmonary fibrosis. Past, present, and future

27 November 2017

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.2.2104050

Treatment of asthma with drugs modifying the leukotriene pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.2.2104050

Constitutive activation of 5-lipoxygenase in the lungs of patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.2.2104050

Leukotrienes, LTC4 and LTB4, in bronchoalveolar lavage in bronchial asthma and other respiratory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.2.2104050

Neutrophil Chemotactic Factors in the Respiratory Tract of Patients with Chronic Airway Diseases or Idiopathic Pulmonary Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.2.2104050

Alveolar macrophages from patients with asbestos exposure release increased levels of leukotriene B4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.2.2104050

Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.2.2104050

gamma-Linolenic acid-containing diet attenuates bleomycin-induced lung fibrosis in hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.2.2104050

Macrophages are a significant source of type 1 cytokines during mycobacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.2.2104050

Dietary fish oil and fish and borage oil suppress intrapulmonary proinflammatory eicosanoid biosynthesis and attenuate pulmonary neutrophil accumulation in endotoxic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.2.2104050

The monocyte-derived neutrophil activating peptide (NAP/interleukin 8) stimulates human neutrophil arachidonate-5-lipoxygenase, but not the release of cellular arachidonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.2.2104050

Transforming growth factor beta upregulates 5-lipoxygenase activity during myeloid cell maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.2.2104050

Leukotriene receptor antagonists and synthesis inhibitors reverse survival in eosinophils of asthmatic individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.2.2104050

Regulation of Alveolar Macrophage Production of Chemoattractants by Leukotrine B4 and Prostaglandin E2

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.2.2104050

Altered inflammatory responses in leukotriene-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.2.2104050

In vivo levels and in vitro production of interferon-gamma in fibrosing interstitial lung diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.2.2104050

A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.2.2104050

Allergic lung responses are increased in prostaglandin H synthase-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.2.2104050

Investigation of the inhibitory effects of PGE2 and selective EP agonists on chemotaxis of human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.2.2104050

Regulation of Human Alveolar Macrophage- and Blood Monocyte-derived Interleukin-8 by Prostaglandin E2 and Dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.2.2104050

Modulation of alveolar macrophage-driven fibroblast proliferation by alternative macrophage mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.2.2104050

Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.2.2104050

Augmentation of functional prostaglandin E levels on the respiratory epithelial surface by aerosol administration of prostaglandin E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.2.2104050

Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.2.2104050

Leukotriene B4 Induces In Vitro Fibroblast Chemotaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.2.2104050

10.1164/AJRCCM.165.2.2104050

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference